Abstract:Antibody discovery technologies, essential for research and therapeutic applications, have evolved significantly since the development of hybridoma technology. Various in vitro (display) and in vivo (animal immunization and B cell-sequencing) workflows have led to the discovery of antibodies against diverse antigens. Despite this success, standard display and B-cell sequencing-based technologies are limited to targets that can be produced in a soluble form. This limitation inhibits the screening of function-inducing antibodies, which require the target to be expressed in cells to monitor function or signaling, and antibodies targeting proteins that maintain their physiological structure only when expressed on cell membranes, such as G-protein coupled receptors (GPCRs). A high-throughput two-cell screening workflow, which localizes an antibody-secreting cell (ASC) and a cell expressing the target protein in a microenvironment, can overcome these challenges. To make function-first plasma cell-based antibody discovery accessible and scalable, we developed hydrogel Nanovials that can capture single plasma cells, target-expressing cells, and plasma cell secretions (antibodies). The detection and isolation of Nanovials harboring the antigen-specific plasma cells are then carried out using a flow cytometry cell sorter - an instrument that is available in most academic centers and biopharmaceutical companies. The antibody discovery workflow employing Nanovials was first validated in the context of two different cell membrane-associated antigens produced in recombinant form. We analyzed over 40,000 plasma cells over two campaigns and were able to identify a diversity of binders that i) exhibited high affinity (picomolar) binding, ii) targeted multiple non-overlapping epitopes and iii) demonstrated high developability scores. A campaign using the two-cell assay targeting the immune checkpoint membrane protein PD-1 yielded cell binders with similar EC50s to clinically used Pembrolizumab and Nivolumab. The highest selectivity for binders was observed for sorted events corresponding with the highest signal bound to target cells on Nanovials. Overall, Nanovials can provide a strong foundation for function-first antibody discovery, yielding direct cell binding information and quantitative data on prioritization of hits with flexibility for additional functional readouts in the future.

Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping

A rapid cell-free expression and screening platform for antibody discovery

A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single‐chain antibody fragments

High-throughput antibody screening with high-quality factor nanophotonics and bioprinting

High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell

Two-dimensional High-Throughput On-Cell Screening of Immunoglobulins Against Broad Antigen Repertoires

A Peptide Microarray Platform Approach for Discovery of Immunodominant Antibody Epitopes

Development of an Antigen-Antibody Co-Display System for Detecting Interaction of G-Protein-Coupled Receptors and Single-Chain Variable Fragments

Multiplex Microscopy Assay for Assessment of Therapeutic and Serum Antibodies against Emerging Pathogens

Rapid and cost-effective epitope mapping using PURE ribosome display coupled with next-generation sequencing and bioinformatics

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run

Rational design based on multi-monomer simultaneous docking for epitope imprinting of SARS-CoV-2 spike protein

A rapid approach for linear epitope vaccine profiling reveals unexpected epitope tag immunogenicity

Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis

Cell-free immuno-profiling on a genetically programmed biochip

Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification

The Rapid and Highly Parallel Identification of Antibodies with Defined Biological Activities by SLISY

Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity

Construction of a Versatile Expression Library for All Human Single-Pass Transmembrane Proteins for Receptor Pairings by High Throughput Screening.

Function-first discovery of high affinity monoclonal antibodies using Nanovial-based plasma B cell screening